<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Structure determination of pyruvate formate-lyase</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Wilhelm</forename><surname>Burmeister</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Biotechnology</orgName>
								<orgName type="institution" key="instit1">University of Turku</orgName>
								<orgName type="institution" key="instit2">Abe Akademi University</orgName>
								<address>
									<postBox>P.O. Box 123</postBox>
									<postCode>FIN-20521</postCode>
									<settlement>Turku</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Adrian</forename><surname>Goldman</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Biotechnology</orgName>
								<orgName type="institution" key="instit1">University of Turku</orgName>
								<orgName type="institution" key="instit2">Abe Akademi University</orgName>
								<address>
									<postBox>P.O. Box 123</postBox>
									<postCode>FIN-20521</postCode>
									<settlement>Turku</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Veli-Matti</forename><surname>Leppanen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Biotechnology</orgName>
								<orgName type="institution" key="instit1">University of Turku</orgName>
								<orgName type="institution" key="instit2">Abe Akademi University</orgName>
								<address>
									<postBox>P.O. Box 123</postBox>
									<postCode>FIN-20521</postCode>
									<settlement>Turku</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Structure determination of pyruvate formate-lyase</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">C6CEDA82C1DD56475658F02D8239CD1A</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T16:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>LS-921</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>Pyruvate forrnate-lyase (PFL, 2 x 85 kDa) catalyses the conversion of pyruvate and coenzyme A into acetyl-CoA and for-mate. It thus catalyses a key step in bacterial anaerobic metabolism, and PFL inhibitors are of potential interest, therefore, as drugs. PFL catalyses proceeds through an acetyl enzyme intermediate with a free radical intermediate. Crystallisation trials with Escherichia coli PFL were unsuccesful and therefore we used limited proteolysis to produce a stable, crystallisable N-terminal protein fragment (69.6 kDa) <ref type="bibr">(Leppanen et aE., manuscript submitted)</ref>. The protein fragment was crystallised in sitting drops using vapour diffusion and the crystals belong to the hexagonal spacegroup P6 1 or P6 5 with cell dimensions a = b = 140.4 A and c = 215.3 A. The crystals can be flashfrozen but diffract very weakly, making synchrotron data collection essential. There are most likely four or two molecules per asymmetric unit (V, of 2.2 or 4.4 respectively), with one local two-fold at w = 8", Q = 0". The crystals, mounted on loops, were transported to ESRF in a liquid nitrogen Dewar having been pre-soaked in heavy-atom reagent and flash-frozen. This way, the potential derivatives from the derivative search using our in-house rotating anode source were saved for futher data collection and the diffraction was confirmed.</p><p>The best native data set before the present was collected to 3.2 A (Rsym 9.4%) on the X31 beamline at DESY. At ESRF the high flux on the beamline ID14 EH3 with an on-line CCD detector allowed rapid data collection to higher resolution with lower R-factors (Table <ref type="table" target="#tab_0">1</ref>). Data was processed on-line using the programs DENZO and SCALEPACK. In the present status of the beamline, both the native and derivative data were collected using the wavelength of highest intensity (0.933 A). Only for one thiomersal derivative (THIOl, table 1) data was collected also above the mercury Lrri absorption edge using the wavelength 1.023 A (TH102). This was not a succesful experiment, because the wavelenghts were not optimised for the mercury edge due to the current, poor tunability and also, because the crystal proved to be poorly derivatized. Earlier derivative search proved mercury compounds to be potential derivatives and, therefore, two more thiomersal and three other mercury derivatives were collected. According to the planned MIR approach other compounds were also tried with the largest differences in intensities in an uranyl acetate derivative.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Isomorphous and anomalous difference Patterson maps calculated with the programs XtalView and FFT (CCP4) for the mercury derivatives show large peaks in the Harker sections. A two site solution for the MEHGl data explains all the major Harker and crosspeaks suggesting two molecules per asymmetric unit with only one major binding site per monomer. The thiomersal Patterson maps have some additional features indicating more binding sites. The signal in anomalous maps is clearly stronger with Harker peaks up to 7 sigma.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>A summary of selected datasets collected at ID14 EH3.</figDesc><table><row><cell>PFL</cell><cell></cell><cell>2.8</cell><cell>0.27</cell><cell>99.3</cell><cell>5.2</cell><cell>22.7</cell></row><row><cell>THIOl</cell><cell>Thiomersal</cell><cell>2.8</cell><cell>0.23</cell><cell>99.5</cell><cell>5.0</cell><cell>22.3 12</cell></row><row><cell>TH102</cell><cell>Thiomersal</cell><cell>3 .O</cell><cell>0.25</cell><cell>99.3</cell><cell>4.0</cell><cell>31.9</cell></row><row><cell>TH104</cell><cell>Thiomersal</cell><cell>3 .O</cell><cell>0.32</cell><cell>99.5</cell><cell>6.3</cell><cell>17.5 20</cell></row><row><cell>MEHGl</cell><cell>Me-Hg-Cl</cell><cell>3 .O</cell><cell>0.43</cell><cell>98.3</cell><cell>5.9</cell><cell>14.9 20</cell></row><row><cell>MEHG2</cell><cell cols="2">Me-Hg-acetate 3 .O</cell><cell>0.30</cell><cell>97.4</cell><cell>6.6</cell><cell>13.6 20</cell></row><row><cell>GOLD1</cell><cell>KAuC14</cell><cell>4.0</cell><cell>0.80</cell><cell>99.4</cell><cell>6.4</cell><cell>14.6 20</cell></row><row><cell>URANl</cell><cell>U02W)2</cell><cell>3.1</cell><cell>0.25</cell><cell>99.8</cell><cell>5.1</cell><cell>19.1 12</cell></row><row><cell>URAN2</cell><cell>U02OW2</cell><cell>3.0</cell><cell>0.49</cell><cell>98.7</cell><cell>5.8</cell><cell>19.4 25</cell></row></table><note><p>Data set Derivative Resol.(A) Mos.(") Compl.(%) Rsym(%) I/O Rise (%)</p></note></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">ESCHERICHIA COLI PYRUVATE FORMATE LYASE LARGE DOMAIN</title>
		<author>
			<persName><forename type="first">V-M</forename><surname>Leppanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Merckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Ollis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kozarich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goldman</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb1qhm/pdb</idno>
		<imprint>
			<date type="published" when="1999-05-19" />
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note>Manuscript submitted</note>
	<note type="raw_reference">Leppanen, V-M., Parast, C.V., Wong, K.K., Kozarich, J.W. &amp; Goldman, A. Purification and crystallisation of a proteolytic fragment of Esherichia coli pyruvate formate-lyase. Manuscript submitted.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
